The cost of elective nodal coverage in prostate cancer: Late quality of life outcomes and dosimetric analysis with 0, 45 or 54 Gy to the pelvis.

Clin Transl Radiat Oncol · 2022 · PMC9256976 · PMID 35813937

Europe PMC DOI

hedged sentence

0.0893

closest p · 1.8× alpha

0.0893

boldest claim

The sentences

trending toward significanceP = 0.0893so close (0.05 < p ≤ 0.1)

52%, p = 0.0148) patients, with urinary function trending toward significance (30% vs. 41%, P = 0.0893).

also in 580 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.